Since our founding in 1984, the Competitive Enterprise Institute has sought to reform and reduce environmental regulation of land, shrink the federal estate, and unlock federal lands for private ownership.
Featured Posts
News Release
The ESA Amendments Act Includes Important Reforms Aimed at Conserving Species and Protecting Property Rights – CEI Paper
There are simple, common-sense reforms to help ensure that the Endangered Species Act (ESA), enacted in 1973, does a better job of conserving species according to a new report from…
Study
The ESA Amendments Act of 2025 Will Help Species
In 1973, the Endangered Species Act (ESA) was enacted into law. Since that time, more than half a century ago, the law has been unsuccessful…
Blog
The problem with the EU’s deforestation regulation
The European Union’s (EU) Deforestation Regulation (EUDR) was adopted in 2023. The stated objective of the EUDR is “to reduce greenhouse gas emissions…
Search Posts
Study
Pick a Number
Full Study Available in PDF How much would you be willing to pay for an…
Op-Eds
A Free-Market Environmental Vision
Full Chapter Available in PDF Format Executive Summary There is one environmental vision, and only one, that is compatible…
Op-Eds
Fire in Paradise: The Yellowstone Fires and the Politics of Environmentalism
ON AUGUST 20, 1988–A DAY THAT came to be known as “Black Saturday”–about 160,000 acres were consumed by fires in the greater Yellowstone Park…
Op-Eds
The Market and Nature
(Originally appeared in The Freeman, September 1993) Many environmentalists are dissatisfied with the environmental record of free economies. Capitalism, it is claimed, is…
Op-Eds
Eco-Apartheid: It’s Africans versus Elephants and Environmentalists
Full document available in pdf format.<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Developing nations regularly complain that……
News Release
Consumer Advocacy Group Attacks FDA for Slow Approval of Cancer Treatment
May 14, 1992—(Washington, DC) The Competitive Enterprise Institute today charged that FDA’s delay in approving Interleukin-2 may have cost as many as 3500 lives. IL-2…
